FDA Registration
Active
🇺🇸 United States
PHARMA SUPPLY, INC.
Reg #: 1066444
·
FEI: 3003405786
·
Expires 2026
Products
11
Proprietary Names
0
Establishment Types
1
Classifications
11
Registration Details
- Registration Name
- PHARMA SUPPLY, INC.
- Registration Number
- 1066444
- FEI Number
- 3003405786
- Status
- Active
- Expiry Year
- 2026
- Initial Importer
- Yes
- Address
- 3361 FAIRLANE FARMS RD.
- City
- Wellington
- State
- FL
- ZIP
- 33414
- Country
- US
Regulatory Submissions
- 510(k) Number
- K120183
Owner / Operator
- Firm Name
- PHARMA SUPPLY, INC.
- Operator Number
- 9046840
- Address
- 3361 FAIRLANE FARMS RD., --
- City
- Wellington
- State
- FL
- Postal Code
- 33414
- Country
- US
- Correspondent
- STEVEN THUSS
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Single (Specified) Analyte Controls (Assayed And Unassayed) | JJX | Class 1 | Clinical Chemistry | No | 2018-12-28 |
| Glucose Oxidase, Glucose | CGA | Class 2 | Clinical Chemistry | No | 2018-12-28 |
| System, Test, Blood Glucose, Over The Counter | NBW | Class 2 | Clinical Chemistry | No | 2018-12-28 |
| Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature | FMK | Class 2 | General, Plastic Surgery | No | 2022-12-02 |
| System, Measurement, Blood-Pressure, Non-Invasive | DXN | Class 2 | Cardiovascular | No | 2018-12-28 |
| Multiple Use Blood Lancet For Single Patient Use Only | QRL | Class 2 | General, Plastic Surgery | No | 2023-12-27 |
| Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature | QRK | Class 2 | General, Plastic Surgery | No | 2022-12-02 |
| Pad, Heating, Powered | IRT | Class 2 | Physical Medicine | No | 2021-11-10 |
| Needle, Hypodermic, Single Lumen | FMI | Class 2 | General Hospital | No | 2024-11-13 |
| Continuous Measurement Thermometer | FLL | Class 2 | General Hospital | No | 2019-12-16 |
| Syringe, Piston | FMF | Class 2 | General Hospital | No | 2022-02-03 |
Establishment Types
Complaint File Establishment per 21 CFR 820.198